This is part of the information: >**Procuring vaccines for COVID-19 - Canada.ca - The total is actually 409 million vaccines or 10.75 per resident.** > >- https://www.canada.ca/en/public-services-procurement/services/procuring-vaccines-covid19.html >- https://web.archive.org/web/20210830052809/https://www.canada.ca/en/public-services-procurement/services/procuring-vaccines-covid19.html >- https://archive.ph/kjdzB > >**Future vaccine supply** >The Government of Canada is securing access to safe and effective COVID-19 vaccines now and into the future. Canada has secured COVID-19 vaccines from Pfizer and Moderna for 2022 and 2023, with options to extend into 2024. > >**Pfizer** >As part of the agreement with Pfizer: > >- Canada has secured access to a guaranteed 35 million doses of Pfizer-BioNTech’s COVID-19 vaccines for 2022, with options for up to 30 million more >- For 2023, Canada has secured access to a guaranteed 30 million doses, with options for 30 million more >- 2024 is an option year. If this option is exercised, Canada will have access to another 30 million doses, with options for an additional 30 million > >In addition to providing booster vaccine doses, the agreement provides flexibility to procure Pfizer’s new COVID-19 vaccine adaptations, such as those to protect against mutations or variants of concern and vaccines developed for younger populations. >These doses are in addition to the 51 million doses of Pfizer-BioNTech’s COVID-19 vaccine arriving before the end of September 2021 as part of Canada’s existing agreement. > >**Moderna** >As part of the agreement with Moderna: > >- Canada has secured access to a guaranteed 20 million doses of COVID-19 vaccines for 2022, with options for up to 15 million more >- For 2023, Canada has secured access to a guaranteed 20 million doses, with options for up to 15 million more >- 2024 is an option year. If this option is exercised, Canada will have access to another 35 million doses > >The agreement will allow access to new COVID-19 vaccine adaptations based on the evolution of the epidemiological situation in Canada. > >**Vaccine-related supplies** >We have put in place contracts for the supplies required to administer nearly 75 million doses of COVID-19 vaccines, including syringes, needles and gauze. To date, we have received enough supplies to administer more than 74 million doses. > >Canada has ordered 282 million syringes of varying sizes to accommodate a range of requirements in the administration of vaccines. This includes 192 million 1 millilitre syringes of which 180.7 million are low-dead volume syringes and 10 million are ultra-low-dead volume syringes. Canada has also ordered 81 million low-dead volume needles.